Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mevalia low protein mini baguette
0913451G0BCAAAC
|
Mevalia food replacer discontinued or OTC rolls/baguettes | Food replacer discontinued or OTC rolls/baguettes (0913451) | Nutrition and Blood | 1 |
|
Generic Loprofin low protein part baked bread rolls
0913451G0AAABAB
|
Food replacer discontinued or OTC rolls/baguettes (0913451) | Food replacer discontinued or OTC rolls/baguettes (0913451) | Nutrition and Blood | No data available |
|
Generic Loprofin low protein part baked rolls
0913451G0AAAAAA
|
Food replacer discontinued or OTC rolls/baguettes (0913451) | Food replacer discontinued or OTC rolls/baguettes (0913451) | Nutrition and Blood | No data available |
|
Generic Mevalia low protein mini baguette
0913451G0AAACAC
|
Food replacer discontinued or OTC rolls/baguettes (0913451) | Food replacer discontinued or OTC rolls/baguettes (0913451) | Nutrition and Blood | No data available |
|
Loprofin low protein part baked bread rolls
0913451G0BBABAB
|
Loprofin food replacer discontinued or OTC rolls/baguettes | Food replacer discontinued or OTC rolls/baguettes (0913451) | Nutrition and Blood | No data available |
|
Loprofin low protein part baked rolls
0913451G0BBAAAA
|
Loprofin food replacer discontinued or OTC rolls/baguettes | Food replacer discontinued or OTC rolls/baguettes (0913451) | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.